c Recently, bioMérieux, France, introduced the Rapidec Carba NP test kit for rapid detection of carbapenemase-producing Gramnegative bacteria. This kit was evaluated in this study, and we report sensitivity, specificity, and positive and negative predictive values of 92.6%, 96.2%, 95.83%, and 92.6%, respectively. The test was easy to perform and interpret and relatively inexpensive ($5/Rs 300 per test) and provides a practical solution for early detection of carbapenemase-producing, multidrug-resistant Gram-negative bacteria.
dent field trial of this kit has been reported by any laboratory worldwide to date, and this study was planned with the aim of evaluating the field efficacy of the Rapidec Carba NP kit in a resource-limited bacteriology laboratory of a developing country like India.
The strains used in this study were collected from various clinical samples of patients admitted to L.L.R & Associated Hospitals (10 hospitals with different superspecialties), GSVM Medical College, Kanpur, and District Hospital, Kanpur, India. All isolated nonduplicate strains were initially screened for carbapenem sensitivity by the disc diffusion method; nonsusceptibility to carbapenems was confirmed by MIC estimation using E strips, and the results were interpreted using the Clinical and Laboratory Standards Institute guidelines (6) . Environmental and surveillance samples were not included in our study. A panel of 100 bacterial isolates were selected for testing: 50 containing different classes of carbapenemases (NDM, KPC, VIM, IMP, and OXA-48, all confirmed by PCR [7] and sequence analysis) and 50 non-carbapenemase producers, of which 25 were sensitive to carbapenem and 25 were resistant to at least one of the carbapenems tested. In the latter group, phenotypic tests for carbapenemase production (modified Hodge test and KPC/MBL confirmation kit; Rosco Diagnostics, Denmark) were also negative; furthermore, to rule out the presence of any carbapenemase activity, carbapenem hydrolysis was performed spectrophotometrically as described earlier (8) , and it was concluded that the carbapenem resistance observed in this group was due to some other mechanism ( Table 1 ). The clonality of the strains of the family Enterobacteriaceae was determined by enterobacterial repetitive intergenic consensus (ERIC) PCR, whereas for nonfermenters, repetitive extragenic palindromic (REP) PCR was performed.
The test was performed as recommended by the manufacturer. A loopful (10-l loop) of a bacterial colony was picked up from overnight-incubated Mueller-Hinton agar plates (bioMérieux) and mixed into API suspension medium (provided with kit); the bacterial suspension was then transferred to wells in the test strip and incubated at 37°C. Visual reading of the test strip was done after 30 min and after 2 h, if necessary. A positive test corresponded to a color change from red to yellow-orange, whereas a red color indicated a negative result (Fig. 1) . The test strips were read by two independent blinded readers to determine interrater reliability. Any discrepancy between the two readings was resolved by an independent blinded third reader, whose reading was taken as final.
The kit detected carbapenemase activity in 46 out of 50 PCRconfirmed strains. However, it could not detect carbapenemase activity in 3 OXA-48-positive strains (two Escherichia coli isolates [nonclonal] and one Klebsiella pneumoniae isolate) and one IMPpositive Escherichia coli strain. False-positive results were also obtained with two carbapenemase-negative carbapenem-resistant (9) 0.06-32 Ϫ Acinetobacter baumannii (6) 0.12-16 Ϫ Klebsiella pneumoniae (8) 0.06-32 Ϫ Proteus mirabilis (2) 0.12-4 Ϫ Citrobacter freundii (2) 0.06-4 Ϫ Enterobacter cloacae (2) 0.12-4 Ϫ a PCR-and imipenem hydrolysis-positive strains. b PCR-and imipenem hydrolysis-negative strains. strains (one Escherichia coli and one Pseudomonas aeruginosa isolate). None of the carbapenem-sensitive bacteria were positive. Overall, the kit showed good efficacy ( Table 2) . To date, the Rapidec Carba NP kit had been evaluated in only two studies. Poirel and Nordmann (4) tested this kit with precharacterized strains and documented a sensitivity and specificity of 96%; they also reported false-negative results with group D carbapenemases, which is in accordance with the fact that group D carbapenemases are known to lack significant carbapenemase activity. In a similar study from the National Reference Center for Antibiotic Resistance, France, Dortet et al. (5) documented a sensitivity of 99% and specificity of 100%.
To conclude, the Rapidec Carba NP test was simple, easy to perform and interpret, and relatively inexpensive ($5/Rs 300 per test) and in most cases gave results in Ͻ30 min. The kit was found to be well suited for rapid detection of NDM, the most common carbapenemase isolated in the Indian subcontinent (9) . The kit can also be used to screen the strains before expensive molecular tests, like PCR and gene sequencing, are performed for identification of the carbapenemase genes. This kit has a high degree of sensitivity and specificity and provides a practical solution for early detection of carbapenemase-producing, multidrug-resistant Gram-negative bacteria in peripheral microbiological laboratories. Further, it will help in implementation of infection prevention and control measures, e.g., patient isolation and quarantine, to limit the spread of carbapenemase producers and avoid outbreaks in health care settings. 
